Mechanisms of Spindle Assembly in Oocytes
Mechanisms of Spindle Assembly in Oocytes
批准号:
9374195
负责人:
MARIA M. VIVEIROS
金额:
$7.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-08-07 至 2019-07-31
关键词:
AddressAgeAgingAneuploidyBinding ProteinsCentriolesCentrosomeChromosome SegregationChromosomesChromosomes, Human, Pair 6ComplexCongenital AbnormalityCongenital DisordersDataDefectDown SyndromeEmbryoExhibitsFemaleFutureGeneticGenetic ModelsGuanosine Triphosphate PhosphohydrolasesHumanKnowledgeMaternal AgeMediatingMeiosisMetaphaseMicrotubule PolymerizationMicrotubule-Organizing CenterMicrotubulesMitosisMitotic spindleModelingMusOocytesPatientsPloidiesPregnancy lossProcessProteinsRNA InterferenceReportingResolutionRoleScaffolding ProteinSmall Interfering RNAStructureStudy modelsTestingTransgenic MiceTransgenic OrganismsWomanadvanced maternal ageblastocystcell typechromosome number abnormalityexperimental studyfetalgamma Tubulingenetic regulatory proteininsightknock-downlive cell imagingmouse modelmutantpericentrinpolymerizationprotein complexprotein expression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
An abnormal chromosome number (aneuploidy) in developing embryos is the leading cause of birth
defects and pregnancy loss in women. The majority of aneuploidies are attributed to error-prone meiotic
division in oocytes and increase significantly with advanced maternal age. Accurate chromosome
segregation is critically dependent on assembly of the microtubule (MT) spindle apparatus and the
establishment of correct chromosome-MT interactions. Our studies in mice demonstrate that disruption of
meiotic spindle stability can promote chromosome segregation errors, which are not fully resolved -despite
spindle checkpoint (SAC) activation. Notably, meiotic spindle formation differs from mitosis as mammalian
oocytes (mouse and human) lack typical centrosomes, with centriole loss occurring during fetal stages.
Alternatively, spindle MT formation can occur from (i) unique acentriolar microtubule-organizing centers
(aMTOCs) and (ii) aMTOC-independent mechanisms in mouse oocytes. In previous studies we identified
pericentin (Pcnt) as an essential aMTOC scaffolding protein. Thus, to test aMTOC function we developed
a unique oocyte-conditional Pcnt knockdown mouse model using a transgenic RNAi approach. Our
recent analysis of oocytes from Tg mice demonstrates that meiotic division is highly error-prone in the
absence of maternal Pcnt and disrupted aMTOCs, leading to female subfertility. Importantly, a new study
reports that human oocytes (obtained from IVF patients), lack pericentrin and show strikingly similar
meiotic errors as our Tg mice. The experiments outlined in this proposal will use this unique genetic
model to address the underlying mechanism(s) of spindle formation in oocytes. In Aim 1 we will
test the function of key aMTOC-independent mechanisms that promote meiotic spindle formation. We will
(i) establish whether Ran activity regulates spindle formation in Pcnt-deficient mouse oocytes and (ii)
undertake the first studies to test if the Augmin complex-mediated MT amplification also functions to
promote spindle stability in mammalian oocytes. Why human oocytes reportedly lack pericentrin and why
aMTOC-independent spindle formation is unstable in oocytes is not known. Thus, experiments in Aim 2
will (i) test the hypothesis that essential aMTOC-associated proteins (pericentrin and γ-tubulin) are
disrupted with increasing maternal age. Additionally, we will (ii) determine whether MT dynamics differ in
Pcnt-deficient oocytes, leading to spindle instability. Knowledge gained from these studies will provide
critical new insight into (i) the key functional mechanisms that promote meiotic spindle formation and (ii)
whether disruption of spindle assembly/stability contributes to age-associated aneuploidy in oocytes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Control of Meiotic Spindle Assembly in Mammalian Oocytes
-
批准号:8232463
-
项目类别:
-
资助金额:$44.55万
-
财政年份:2012
-
负责人:MARIA M. VIVEIROS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: